ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada

Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice.

Jamil Asselah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.